Hepatitis B
Conditions
Brief summary
The aim of this study is to evaluate the prevalence of hepatitis B in Vallés Occidental. Also, describe the stage of the disease, and whether if they are under medical treatment or not.
Detailed description
The hepatitis B virus ( HBV ) is a global health problem . It is estimated that in the world there are about 350-400 million carriers of HBV surface antigen ( HBsAg ) 1 . The prevalence in Spain is estimated at a 2-7 % and is considered a second intermediate prevalence. For over 20 years, has carried out a program of primary prevention through universal vaccination against hepatitis B including it in the childhood vaccination schedule and has already been observed that in some estudi3 the prevalence has declined . For this reason , we want to evaluate what is the currently prevalence in our area of influence. There aren't recent studies to assess what is the current status of these patients ( how many , what risk factors which needs of treatment and with answer ...)
Interventions
OTHERNot apply
None. Just registration epidemiology dates
Sponsors
Hospital Mutua de Terrassa
Consorci Sanitari de Terrassa
Corporacion Parc Tauli
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Patients with HBsAg + visited in Digestive/Hepatology outpatient visits and Hepatology of the participating hospitals
Exclusion criteria
* Patients \< 18 aged * Duplicity on record
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevalence hepatitis B | 12 months |
Secondary
| Measure | Time frame |
|---|---|
| stage of the disease and if they are in treatment or not | 1 day |
Countries
Spain
Outcome results
None listed